首页 | 本学科首页   官方微博 | 高级检索  
     

国产与进口重组人红细胞生成素治疗血透病人贫血的比较
引用本文:余春华,陈树元,刘雪芬. 国产与进口重组人红细胞生成素治疗血透病人贫血的比较[J]. 中国新药与临床杂志, 1999, 18(4): 207-209
作者姓名:余春华  陈树元  刘雪芬
作者单位:1. 农垦燕岭医院血液净化中心,广东广州510507
2. 中国人民解放军第一军医大学附属南方医院临床药理室,广东广州,510515
摘    要:
目的:研究国产重组人红细胞生成素(rh E P O) 对慢性肾功能衰竭伴肾性贫血的临床疗效。方法:将68 例慢性肾功能衰竭伴肾性贫血的血液透析( 血透) 病人随机分成国产rh E P O 组38 例( 男性22例,女性16 例;年龄45 a ±s 4 a) 予国产rh E P O 80~160 U/kg ,iv , 进口rh E P O 组30 例( 男性18 例,女性12 例;年龄41 a ±3 a) 予进口rh E P O 30 ~80 U/kg ,iv , 均为每周2 ~3 次,连续用药治疗24 wk ,观察血红蛋白( Hb) 、血细胞比容( Hct) 、血清铁和血清铁蛋白的动态变化。结果:国产rh E P O 组总有效率为95 % 。进口rh E P O 组总有效率为100 % ( P>0 .05) ,2 组各有2 例因出现血压升高而被迫停药。结论:国产rh E P O(80 ~160 U/kg) 的疗效基本上与进口rh E P O 组(30 ~80 U/kg) 一致。

关 键 词:慢性肾功能衰竭  贫血  血液透析  重组红细胞生成素

Domestic vs imported recombinant human erythropoietin in treatment of anemia in hemodialysis patients
YU Chun-Hua,CHEN Shu-Yuan,LIU Xue-Fen. Domestic vs imported recombinant human erythropoietin in treatment of anemia in hemodialysis patients[J]. Chinese Journal of New Drugs and Clinical Remedies, 1999, 18(4): 207-209
Authors:YU Chun-Hua  CHEN Shu-Yuan  LIU Xue-Fen
Abstract:
AIM: To study the effects of domestic rhEPO on patients with anemia of chronic renal failure under hemodialysis. METHODS: Sixty_eight patients hemodialysis with anemia of chronic renal failure were randomly divided into rhEPO group (38 patients, M 22, F 16; age 45 a±s 4 a) received domestic rhEPO 80_160 U/kg, iv, and imported rhEPO group (30 patients, M 18, F 12; age 41 a±3 a) received imported rhEPO 30_80 U/kg, iv, 2_3 times per week for 24 wk. RESULTS: The total effective rates of domestic and imported group were 95% and 100%, respectively, P>0.05. CONCLUSION: The effects of domestic rhEPO (80_160 U/kg) and imported rhEPO (30_80 U/kg) on anemia of chronic renal failure in hemodialysis patients and their adverse reactions were similar.
Keywords:chronic kidney failure   anemia   hemodialysis   recombinant erythropoietin 
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号